Sailong Pharmaceutical Group Co (SZSE:002898) Total Assets : ¥784.3 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co Total Assets?

Sailong Pharmaceutical Group Co's Total Assets for the quarter that ended in Mar. 2024 was ¥784.3 Mil.

During the past 12 months, Sailong Pharmaceutical Group Co's average Total Assets Growth Rate was -7.00% per year. During the past 3 years, the average Total Assets Growth Rate was -1.50% per year. During the past 5 years, the average Total Assets Growth Rate was 4.50% per year. During the past 10 years, the average Total Assets Growth Rate was 24.40% per year.

During the past 11 years, Sailong Pharmaceutical Group Co's highest 3-Year average Total Assets Growth Rate was 47.20%. The lowest was -1.50%. And the median was 30.50%.

Total Assets is connected with ROA %. Sailong Pharmaceutical Group Co's annualized ROA % for the quarter that ended in Mar. 2024 was 0.81%. Total Assets is also linked to Revenue through Asset Turnover. Sailong Pharmaceutical Group Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.09.

Sailong Pharmaceutical Group Co Total Assets Historical Data

The historical data trend for Sailong Pharmaceutical Group Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sailong Pharmaceutical Group Co Total Assets Chart

Sailong Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

835.98

816.69

882.79

848.02

813.84

Sailong Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															827.26	857.21	812.63	813.84	784.31

Sailong Pharmaceutical Group Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sailong Pharmaceutical Group Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	535.882	+	277.962
	=	813.8

Sailong Pharmaceutical Group Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	537.506	+	246.802
	=	784.3

Sailong Pharmaceutical Group Co (SZSE:002898) Total Assets Explanation

Total Assets is connected with ROA %.

Sailong Pharmaceutical Group Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	6.496	/	( (813.844	+	784.308)	/ 2 )
	=	6.496	/	799.076
	=	0.81 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sailong Pharmaceutical Group Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	69.484	/	( (813.844	+	784.308)	/ 2 )
=	69.484	/	799.076
=	0.09

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sailong Pharmaceutical Group Co Total Assets Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sailong Pharmaceutical Group Co (SZSE:002898) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015

Website

http://www.sailong.cn

Zhuhai Sailong Pharmaceutical Co Ltd is the pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.

Executives

Tang Lin	Director
Long Zhi Xiang	Director
Deng Yong Jun	Supervisors
Zhou Bei	Supervisors
Li Jian Feng	Directors, executives

Sailong Pharmaceutical Group Co (SZSE:002898) Headlines

No Headlines